ArticlePediatric rheumatology online journal2026
Muscle mass, strength, and sarcopenia in juvenile idiopathic arthritis: a scoping review.
Article in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMuscle deficits are a recognized complication of juvenile idiopathic arthritis (JIA), but the long-term consequences of these alterations into adulthood are not well defined. This scoping review aims to synthesize the current evidence on both muscle mass and muscle strength deficits in JIA, contextualizing these findings within the modern framework of sarcopenia and their relevance for adult care.
methodsA scoping review of the literature was conducted using PubMed/Medline, EMBASE, and Cochrane databases (up to September 2025) to identify studies that assessed muscle mass (by dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, or bioelectrical impedance analysis) or muscle strength (by dynamometry) in JIA patients.
resultsThe synthesis included 37 studies comprising 2,040 patients. Findings on muscle mass (n = 21 studies) were heterogeneous, with a majority of comparative studies (9 of 14, 64%) reporting significantly lower lean mass, a finding primarily linked to high disease activity. In contrast, the evidence regarding muscle strength (n = 10 studies) was more definitive in identifying a deficit. All cross-sectional studies (3 of 3) that compared JIA patients to controls found significant weakness, which strongly correlated with disease activity and disability. Furthermore, a majority of interventional trials (5 of 7) demonstrated that this weakness is responsive to exercise. Comprehensive studies (n = 6) revealed a critical “mass–strength dissociation” and reported a high prevalence of sarcopenia (59%) in a young-adult cohort, strongly associated with high disease activity and accumulated damage.
conclusionMuscle deficits in JIA are a multifaceted problem encompassing both atrophy and weakness, with reports of a high sarcopenia burden that can persist into young adulthood. These findings highlight the importance of routinely assessing both muscle mass and strength as part of long-term management for adults with a history of JIA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.